The ethics of using safe gene therapies to improve the health and cognition of Down syndrome children and adults.
EditCo Bio and Promega have announced a strategic licensing agreement that grants EditCo access to Promega’s HiBiT, HaloTag, and NanoLuc technologies. Under the terms of the arrangement, EditCo will ...
A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR technologies in the field of regenerative medicine. The study, authored by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results